This session will explore evolving approaches to upper limb recovery and restoration for people with cervical spinal cord injury, highlighting how contemporary interventions are shaping functional recovery. Drawing on data from recent and ongoing studies, Dr. Kalsi-Ryan will review trends in trial design and outcome selection, with a particular emphasis on the Graded Redefined Assessment of Strength, Sensibility and Prehension (GRASSP) and the Spinal Cord Independence Measure (SCIM) as complementary tools to capture upper limb impairment and real-world functional independence. By examining how changes in GRASSP domains map onto SCIM scores, the presentation will illustrate the clinical relevance of upper limb gains and the practical benefits for daily activities. The session will conclude by outlining key lessons for the next phase of study design, including optimizing outcome measures, aligning interventions with meaningful patient-centered goals, and identifying emerging opportunities that have the potential to transform life for individuals living with cervical spinal cord injury.

Dr. Kalsi-Ryan is a Clinician Scientist in the field of neurological rehabilitation with a special interest in upper limb assessment, recovery, neuro-restoration. Her research is oriented to establishing methods to quantify neurological change after injury and studying neuro-restorative methods to enhance and optimize function for those with neurological impairment. Her current role is as the PI of the Upper Extremity Neuro-Restorative Innovations Lab, where she uses evidence as the foundation for the implementation of new and existing clinical practices. She serves as a member of the Board of Directors of the Canadian Physiotherapy Association, an Editorial Board Member of Archives of Physical Medicine and Rehabilitation and as a member of the RECODE-DCM Steering Committee.  

Dr. Kalsi-Ryan provides academic teaching within the Neurosurgical Resident training, Rehabilitation Sciences Institute, Institute of Medical Sciences and Physical Therapy programs at the University of Toronto. She is the founder of her own company, which manufactures the GRASSP and she herself, acts as a consultant to device and pharmaceutical companies worldwide.